Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information
The Management Board of Celon Pharma S.A. (“Company”) hereby informs that in the “Half-Year Condensed Financial Statements for the 6-month period ended June 30, 2023” published by the Company on 20 September 2023, there was, for technical reasons, a mistake in the presentation of data for the period April 1-June 30 2022 in the Statement of Comprehensive Income and in the Segment Note.
Immediately following the publication of this current report, the Company will publish a revised periodical report for 1H2023, as required by Article 15 (4) of the Regulation of the Minister of Finance of March 29, 2018 on current and periodic information provided by issuers of securities (...). The appendix to this current report presents the tables with the revised data